（图片系AI生成） 12月9日，嘉美包装（002969.SZ）一则"筹划控制权变更"公告，坐实了市场早已用涨停预演的"易主"传 闻。 根据公告，嘉美包装控股股东中国食品包装有限公司（以下简称"中包香港"）正筹划控制权变更事宜， 可能导致公司实际控制人发生变更，股票自12月10日起停牌不超过2个交易日。 对此市场先知先觉，公司股价提前异动，12月5日涨停、12月9日大涨7.8%，收报4.56元/股，近3个交易 日涨幅超16%，近6个交易日涨幅近20%，创近3年半新高，最新市值达43.6亿元。 控股股东"边减边退"、主业缺乏新增长点，嘉美包装的资本故事已走到十字路口。接下来，谁来接盘， 新主又将如何提振上市公司业绩将是市场关注焦点。 股东轮番减持"上瘾" 除股东外，公司高管也加入减持行列。董事张悟开曾在2023年8月至11月期间减持120万股，套现494.4 万元。 对于股东减持，公司称富新投资等股东属于财务投资，减持基于自身业务规划，与公司经营无关，但密 集减持仍引发市场关注，尤其对于第二三大股东富新投资与中凯投资近乎"常态化"的套现操作，市场情 绪颇大。在此背景下，"控制权变更"的消息恰好成为打破这一僵局的关 ...

【导读】嘉美包装控股股东中包香港正在筹划控制权变更 中国基金报记者 若文 12月9日，嘉美包装公告称，公司控股股东中包香港正在筹划控制权变更事宜，可能导致公司实际控制 人发生变更。经申请，公司股票自2025年12月10日开市起停牌，预计不超过2个交易日。目前事项尚处 于意向阶段，存在重大不确定性。 据公司官网，嘉美包装是一家全产业链服务于饮料品牌的平台企业，为客户提供全品类饮料包装容器的 研发、设计、生产、销售；全品类的饮料配方研发、灌装生产及饮料渠道营销的各项服务。 上市公司旗下拥有17家企业，涵盖印铁、三片罐、两片罐、ABC罐、TBC罐、SBC罐、无菌纸包、各包 材配套的饮料灌装OEM等多项业务板块。 据悉，嘉美包装主要客户包括养元饮品、王老吉、银鹭集团、达利集团、承德露露、喜多多等，其中， 养元饮品为上市公司关联方。 截至2025年9月30日，公司控股股东中包香港持有嘉美包装44.75%的股份，公司实控人为陈民、厉翠 玲。值得一提的是，11月18日，中包香港公告称，计划以集中竞价交易或大宗交易方式减持不超过150 万股，占公司总股本比例为0.16%。 嘉美包装表示，目前，各方主体正在就具体交易方案、协议 ...

中国基金报记者 若文 12月9日，嘉美包装公告称，公司控股股东中包香港正在筹划控制权变更事宜，可能导致公司 实际控制人发生变更。经申请，公司股票自2025年12月10日开市起停牌，预计不超过2个交 易日。目前事项尚处于意向阶段，存在重大不确定性。 【导读】嘉美包装控股股东中包香港正在筹划控制权变更 嘉美包装表示，目前，各方主体正在就具体交易方案、协议等相关事项进行论证和磋商，具 体情况以各方签订的相关协议为准。 据公司官网，嘉美包装是一家全产业链服务于饮料品牌的平台企业，为客户提供全品类饮料 包装容器的研发、设计、生产、销售；全品类的饮料配方研发、灌装生产及饮料渠道营销的 各项服务。 上市公司旗下拥有17家企业，涵盖印铁、三片罐、两片罐、ABC罐、TBC罐、SBC罐、无菌 纸包、各包材配套的饮料灌装OEM等多项业务板块。 据悉，嘉美包装主要客户包括养元饮品、王老吉、银鹭集团、达利集团、承德露露、喜多多 等，其中，养元饮品为上市公司关联方。 同日，第二、第三大股东富新投资和中凯投资也抛出减持计划，拟以集中竞价交易方式合计 减持约934万股，占公司总股本比例为1%。据三季报披露，富新投资和中凯投资分别持有上 市公 ...

【导读】嘉美包装控股股东中包香港正在筹划控制权变更 中国基金报记者 若文 12月9日，嘉美包装公告称，公司控股股东中包香港正在筹划控制权变更事宜，可能导致公司实际控制人发生变更。经申请，公司股票自2025年12月10日 开市起停牌，预计不超过2个交易日。目前事项尚处于意向阶段，存在重大不确定性。 嘉美包装表示，目前，各方主体正在就具体交易方案、协议等相关事项进行论证和磋商，具体情况以各方签订的相关协议为准。 上市公司旗下拥有17家企业，涵盖印铁、三片罐、两片罐、ABC罐、TBC罐、SBC罐、无菌纸包、各包材配套的饮料灌装OEM等多项业务板块。 据悉，嘉美包装主要客户包括养元饮品、王老吉、银鹭集团、达利集团、承德露露、喜多多等，其中，养元饮品为上市公司关联方。 截至2025年9月30日，公司控股股东中包香港持有嘉美包装44.75%的股份，公司实控人为陈民、厉翠玲。值得一提的是，11月18日，中包香港公告称，计 划以集中竞价交易或大宗交易方式减持不超过150万股，占公司总股本比例为0.16%。 据公司官网，嘉美包装是一家全产业链服务于饮料品牌的平台企业，为客户提供全品类饮料包装容器的研发、设计、生产、销售；全品类 ...

Group 1 - Jinggong Technology signed a sales contract with Hubei Yuchuang worth 729 million yuan, accounting for 42.16% of the company's audited revenue for 2024 [1] - Heshun Electric is expected to win a bid for a State Grid procurement project worth 107 million yuan, representing 24.97% of the company's 2024 revenue [2] - Yongmaotai plans to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy materials [3] Group 2 - Longi Green Energy announced the termination of its plan to issue global depositary receipts abroad, stating it will not significantly impact its operations [4] - Bai Ao Intelligent is expected to win bids for projects totaling 27.5 million yuan [5] - Lian Biological is planning a change of control and asset purchase, leading to a temporary suspension of its stock [6] Group 3 - Bo Rui Communication intends to acquire 51% of Meijing Technology for 66.49 million yuan [7] - Huitai Medical plans to repurchase shares worth 200 to 250 million yuan for employee stock ownership plans [8] - Yifang Biological is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 4 - Jiuqiang Biological's shareholders signed an agreement for the transfer of 5% of the company's shares to China National Pharmaceutical Investment [11] - Songcheng Performing Arts plans to repurchase shares worth 100 to 200 million yuan for capital reduction [12] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project in Jiangxi Province [13] Group 5 - Xingfu Electronics plans to invest 480 million yuan in a new electronic-grade phosphoric acid project [14] - Jiaao Environmental Protection's stock will be subject to risk warnings due to an administrative penalty [15] - ST Nuotai received a drug registration certificate for a new injection [16] Group 6 - Haimo Technology plans to sell its controlling subsidiary, Xian Sitian Instrument, for 370 million yuan [17] - Jingce Electronics signed multiple sales contracts with a single customer totaling 433 million yuan [18] - Donghua Testing's controlling shareholder plans to reduce its stake by up to 1.99% [19][20] Group 7 - Xingqi Eye Medicine completed the first subject enrollment for a Phase II clinical trial of its eye drop product [21] - Kute Intelligent's controlling shareholder plans to reduce its stake by up to 2% [22] - Dongcheng Pharmaceutical's subsidiary received approval for a new specification of a heparin sodium injection [23] Group 8 - Zhaoyi Innovation is in the process of issuing H-shares and has received regulatory approval [24] - Aokang International's shareholder plans to reduce its stake by up to 3% [25] - Jiamei Packaging's controlling shareholder is planning a change of control, leading to a temporary stock suspension [26] Group 9 - ST Kevin's stock will have its risk warning lifted and will resume trading [27] - Zaiseng Technology's controlling shareholder plans to transfer 6.04% of the company's shares [28] - Lide New Energy's shareholder plans to reduce its stake by up to 1% [29] Group 10 - Srypu terminated its plan to acquire shares and will resume trading [30] - Longjiang Transportation's subsidiary plans to invest 2.679 billion yuan in a graphite mining project [31] - Haowei Group's controlling shareholder has not reduced its stake and has terminated the reduction plan [32] Group 11 - Huilun Crystal received an administrative penalty notice for information disclosure violations [33] - Haiguang Information terminated a major asset restructuring plan [34] - Zhongke Shuguang announced a cash dividend plan [35] Group 12 - Fushuo Technology's share purchase plan was approved by the Shenzhen Stock Exchange [36] - Dongbai Group's shareholder reduced its stake by 25.95 million shares [38]

Group 1 - The Chinese Ministry of Foreign Affairs noted the U.S. decision to allow NVIDIA to sell H200 AI chips to approved customers in China, emphasizing the importance of cooperation for mutual benefit between China and the U.S. [1] - The Chinese Ministry of Commerce highlighted the retail sector as a key focus for developing a complete domestic demand system and promoting high-quality development during the 14th Five-Year Plan period [1] - A new multi-crystalline silicon capacity integration acquisition platform named Beijing Guanghe Qiancheng Technology Co., Ltd. has been established with a registered capital of 3 billion, aimed at exploring strategic cooperation opportunities within the industry [1] Group 2 - The Ministry of Agriculture and Rural Affairs reported that pork supply in November was sufficient, with prices slightly decreasing. The number of breeding sows fell to 39.9 million, marking a 1.1% month-on-month decrease and a 2.1% year-on-year decrease [2] - The Quanzhou Municipal Committee proposed initiatives to enhance infrastructure connectivity with Taiwan, including improving transportation and utilities, and supporting Taiwanese residents in various aspects of life in Quanzhou [2] Group 3 - The draft measures to promote the sales of liquor in Guizhou include supporting collaboration between liquor companies and financial institutions, exploring new financial products, and ensuring product quality while combating market violations [3]

Group 1 - Rhein Biotech and Jia Mei Packaging's controlling shareholders are planning changes in company control, with trading suspension starting from December 10, 2025, for Rhein Biotech expected to last no more than 10 trading days and for Jia Mei Packaging no more than 2 trading days [1][2] - Rhein Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of issuing shares and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1] - Jia Mei Packaging's controlling shareholder is also in discussions regarding a potential change in control, with specific transaction details still under negotiation [2] Group 2 - Haiguang Information has terminated its plan to merge with Zhongke Shuguang through a share exchange, as approved in a board meeting on December 9, 2025 [3] - Huatai Medical plans to repurchase shares with a total amount not less than RMB 200 million and not exceeding RMB 250 million, with a repurchase price cap of RMB 315 per share [4] - Songcheng Performing Arts and Jingu Co., Ltd. also announced share repurchase plans, with Songcheng aiming for a total of RMB 100 million to RMB 200 million and Jingu targeting RMB 30 million to RMB 60 million [4] Group 3 - Xiamen Airport is planning to acquire 100% of the shares of Zhaoxiang Technology, a wholly-owned subsidiary of its controlling shareholder, Xiamen Xiangye Group [5] - Borui Communication intends to acquire 51% of Meijing Technology from related parties for a total price of RMB 66.49 million [6] - Gu Ao Technology's actual controller is planning a change in control, with trading suspension starting from December 8, 2025, and expected to last no more than 3 trading days [6] Group 4 - ST Kevin's application to revoke the risk warning on its stock has been approved, with trading suspension for one day on December 10, 2025, and resuming trading on December 11, 2025 [6] - Huailun Crystal's stock will be suspended for one day starting December 10, 2025, due to false disclosures in its annual reports for 2021 and 2022 [7] - The stock of Jia Ao Environmental Protection will also be suspended for one day on December 10, 2025, due to an administrative penalty notice received from the regulatory authority [12] Group 5 - The company Yongmota plans to invest approximately RMB 400 million in a new project for magnesium-aluminum alloy components for the automotive and robotics industries [20] - ST Ningke is executing a capital reserve transfer plan to increase its share capital, with a total share increase from 684.88 million to 1.62 billion shares [21] - Yingpais plans to increase its shareholding through a combination of bank loans and self-funding, with a total investment of no less than RMB 60 million and no more than RMB 120 million [22]

以下是第一财经对一些重要公告的汇总，供投资者参考。 【品大事】 中科曙光：终止海光信息换股吸收合并公司并募集配套资金 中科曙光公告称，公司于2025年12月9日召开董事会，审议通过了《关于公司终止重大资产重组的议案》，同意终止海光信息通过向中科曙光全体A股换股 股东发行A股股票的方式换股吸收合并中科曙光并募集配套资金，并授权公司管理层办理本次终止的相关事宜。主要原因是交易规模大、涉及相关方多，导 致方案论证历时较长，且目前市场环境较筹划之初发生较大变化，实施条件尚不成熟。公司与交易各相关方协商后决定终止该事项。此次交易终止不会对公 司生产经营和财务状况造成重大不利影响。 惠伦晶体：因2021年、2022年年度报告存在虚假记载 公司股票被实施其他风险警示 惠伦晶体公告称，公司因2021年、2022年年度报告存在虚假记载，根据广东证监局的《行政处罚事先告知书》以及深交所相关规定，公司股票交易将被实施 其他风险警示，股票简称由"惠伦晶体"变更为"ST惠伦"，股票代码不变，仍为"300460"。实施其他风险警示后，股票交易日涨跌幅限制不变，仍为20%。公 司将在满足条件后向深交所申请撤销其他风险警示。公司股票自202 ...

该事项正在洽谈中，目前尚存在重大不确定性。为保证公平信息披露，维护投资者利益，避免公司 股价异常波动，根据《深圳证券交易所股票上市规则》和《深圳证券交易所上市公司自律监管指引第6 号——停复牌》等相关规定，经公司向深圳证券交易所申请，公司股票（股票简称：嘉美包装，股票代 码：002969）自2025年12月10日（星期三）开市起停牌，预计停牌时间不超过2个交易日。 嘉美包装表示，停牌期间，公司将根据相关事项进展情况，严格按照有关法律法规的规定和要求履 行信息披露义务。待上述事项确定后，公司将及时发布相关公告并申请公司股票复牌。 (责任编辑：何潇) 中国经济网北京12月9日讯 嘉美包装(002969.SZ)今日晚间披露关于关于筹划控制权变更事项停牌的 公告称，公司近日收到控股股东中包香港的通知，获悉中包香港正在筹划有关公司控制权变更事宜，该 事项可能导致公司控股股东、实际控制人发生变更。目前，各方主体正在就具体交易方案、协议等相关 事项进行论证和磋商，具体情况以各方签订的相关协议为准。 ...

北京商报讯（记者 马换换 李佳雪）12月9日晚间，嘉美包装（002969）披露公告称，公司近日收到控股 股东中包香港的通知，获悉中包香港正在筹划有关公司控制权变更事宜，该事项可能导致公司控股股 东、实际控制人发生变更。公司股票自12月10日开市起停牌，预计停牌时间不超过2个交易日。 交易行情显示，12月9日，嘉美包装大幅收涨7.8%，收于4.56元/股，总市值43.57亿元。 嘉美包装表示，目前，各方主体正在就具体交易方案、协议等相关事项进行论证和磋商，具体情况以各 方签订的相关协议为准。 ...